Related Experiment Video
Updated: Jan 11, 2026

Neuronavigation and Laparoscopy Guided Ventriculoperitoneal Shunt Insertion for the Treatment of Hydrocephalus
Published on: October 14, 2022
Primary PreserFlo MicroShunt Versus Trabeculectomy: Effectiveness and Safety in the Real World
Anoushka N Kothari1, Graham A Lee1,2
1Mayne Academy of Surgery, University of Queensland, Brisbane, QLD 4006, Australia.
Abstract:
Backgrounds/Objectives: Trabeculectomy is the gold standard for glaucoma drainage surgery, but it is associated with a risk of sight-threatening complications. The PreserFlo MicroShunt (PF) is a less invasive alternative that aims to reduce complications and simplify post-operative care. This study aimed to compare the effectiveness and safety of PF to trabeculectomy in the management of glaucoma. Methods: This was a retrospective cohort analysis of 95 eyes (48 PF, 47 trabeculectomy) from a single-center private practice in Brisbane, Australia. Data were collected from November 2017 to January 2024. Primary outcomes included intraocular pressure (IOP) and the number of medications. Secondary outcomes included best-corrected visual acuity (BCVA) and complications. Inverse probability of treatment weighting (IPTW) was applied to baseline covariates, and weighted regression and Cox proportional hazards models were then used to estimate treatment effects. Results: The two groups had comparable patient characteristics, although the PF group was older with worse visual field mean deviation. At 12 months, both procedures significantly reduced IOP and medications; however, differences were not statistically significant between groups (2.9 mmHg; 95%CI: -2.0, 7.9; p = 0.303, and 0.4; 95%CI: -0.13, 0.96; p = 0.138, respectively). The estimated probabilities of qualified success were comparable (74.9% PF vs. 72.5% trabeculectomy). Intra-operative stenting in PF eyes eliminated early post-operative hypotony. The incidence of open surgical revision in the PF group vs. the trabeculectomy group was 14.6% vs. 2.1% (p = 0.059, respectively). PF was associated with faster post-operative inflammation resolution (hazard ratio: 6.3; 95%CI: 2.8, 14.5; p < 0.001). Conclusions: Both PF and trabeculectomy are effective for glaucoma management. PF is a less invasive procedure with a lower rate of early hypotony when stented. Trabeculectomy has a tendency for lower IOP reduction and less requirement for open revision, although this did not reach statistical significance. This highlights the need for longer-term studies and improved techniques, such as more effective anti-fibrotic strategies.
Insights
PreserFlo MicroShunt (PF) and trabeculectomy effectively manage glaucoma by lowering intraocular pressure (IOP). PF offers faster inflammation resolution and less hypotony, while trabeculectomy shows a trend toward greater IOP reduction.
Area of Science:
- Ophthalmology
- Surgical Innovation
- Glaucoma Management
Background:
- Trabeculectomy is the standard glaucoma surgery but carries risks of serious complications.
- The PreserFlo MicroShunt (PF) offers a less invasive surgical option for glaucoma management.
- Comparing the safety and efficacy of PF against trabeculectomy is crucial for surgical decision-making.
Purpose of the Study:
- To compare the effectiveness and safety of the PreserFlo MicroShunt (PF) versus trabeculectomy for glaucoma treatment.
- To evaluate intraocular pressure (IOP) reduction, medication usage, and complication rates between the two surgical methods.
- To assess visual acuity and post-operative recovery metrics in patients undergoing PF or trabeculectomy.
Main Methods:
- Retrospective cohort analysis of 95 eyes (48 PF, 47 trabeculectomy) from a single Australian private practice.
- Data collected from November 2017 to January 2024, utilizing Inverse Probability of Treatment Weighting (IPTW) for covariate adjustment.
- Weighted regression and Cox proportional hazards models were employed to estimate treatment effects on primary and secondary outcomes.
Main Results:
- Both PF and trabeculectomy significantly reduced IOP and medication needs at 12 months, with no statistically significant difference between groups.
- Qualified success rates were comparable (74.9% PF vs. 72.5% trabeculectomy).
- PF demonstrated a lower incidence of early hypotony (when stented) and faster post-operative inflammation resolution (HR: 6.3, p < 0.001), while trabeculectomy showed a non-significant trend towards lower IOP and fewer revisions.
Conclusions:
- Both PreserFlo MicroShunt and trabeculectomy are effective glaucoma surgical options.
- PF is a less invasive procedure associated with reduced early hypotony and quicker inflammation recovery.
- Further long-term studies and enhanced anti-fibrotic strategies are needed to optimize glaucoma surgical outcomes.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment

